Search for: "Mylan, Inc." Results 21 - 40 of 587
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
10 Feb 2014, 8:37 am
Mylan Inc., the patch had to be defined under the state's product liability law as it pertains to drug manufacturers. [read post]
2 Aug 2023, 11:05 am by Sofya Asatryan
Sanofi argued on appeal that the Board erroneously agreed with Mylan’s argument that de Gennes constituted analogous art because Mylan incorrectly compared the de Gennes reference to another prior art reference, and not the ’614 patent. [read post]
8 Nov 2021, 9:15 am by Steve Brachmann
Mylan Pharmaceuticals Inc. affirming a ruling of the District of Delaware, which dismissed a Hatch-Waxman lawsuit against related Mylan entities for either improper venue or failure to state a claim upon which relief could be granted. [read post]
12 Dec 2011, 9:59 pm by Patent Docs
Mylan Pharmaceuticals Inc., an ANDA case brought before Judge Martini in the New Jersey District Court. [read post]
17 Dec 2010, 7:47 am by Lawrence B. Ebert
(Nasdaq: MYL) today confirmed that the company and its subsidiary Mylan Pharmaceuticals Inc. have been sued by Shionogi Pharma Inc. and CIMA LABS INC. in connection with the filing of an Abbreviated New Drug Application (ANDA) with the U.S. [read post]
21 Oct 2009, 6:08 pm by mcarzima@imediainc.com
Generic drug maker, Mylan Inc, will pay the U.S government $121 million to settle a civil dispute, started by a whistleblower, involving Medicaid rebates on drug sales from 2000 to 2004. [read post]
21 Oct 2009, 6:08 pm
Generic drug maker, Mylan Inc, will pay the U.S government $121 million to settle a civil dispute, started by a whistleblower, involving Medicaid rebates on drug sales from 2000 to 2004. [read post]
31 Dec 2010, 2:46 am by Bob Kraft
The  drug maker Mylan Inc. has agreed to settle a lawsuit brought against it by both the U.S. government and the State of Texas. [read post]
1 Oct 2022, 2:31 pm by Lawrence B. Ebert
The outcome: Mylan Pharmaceuticals Inc. [read post]
15 Aug 2022, 3:10 am by Moll Law Group
Early in July, Mylan Pharmaceuticals, Inc. voluntarily recalled a batch of its prefilled Insulin Glargine Injection pens that come in 100 units/mL, 3 mL. [read post]
9 Dec 2021, 7:15 am by Logan Murr
On December 8, the United States Court of Appeals for the Federal Circuit (CAFC), in a precedential decision authored by Judge Stoll, vacated a  judgment of infringement against Mylan Pharmaceuticals Inc. and affirmed the nonobvious determination of the United States District Court for the Northern District of West Virginia. [read post]
24 Jun 2010, 1:47 pm by Joseph Sano
On June 18, 2010 the Supreme Court of Appeals of West Virginia filed its decision in favor of CGL and Umbrella insurers in Mylan Laboratories, Inc v. [read post]
21 Oct 2011, 7:40 am by Phil
The following is excerpted from an October 20, 2011 Mylan press release available on its website: Dey Pharma L.P., a subsidiary of Mylan Inc. [read post]